One of the latest novel medications developed to treat type 2 diabetes is Victoza. Made by the pharmaceutical company, Novo Nordisk of Denmark, Victoza has gained a lot of favorable reports. Victoza® is the brand name for Liraglutide and is the first once a day drug for treatment of type 2 diabetes. Unlike previous oral hypoglycemic drugs, Victoza is actually human glucagon like peptide and is only administered via an injection. Experts in diabetes claim that Victoza has several advantages for diabetics.
These include:
Can be combined with metformin or other oral hypoglycemic agent in patients with poor sugar control despite maximal tolerated dose of metformin or other oral hypoglycemics.
The drug can help diabetics lose weight.
It does not cause profound drop in blood sugars.
The drug is undergoing final evaluation by the FDA and news of its release in the North American market is expected soon. Clinical Studies from Europe involving thousands of diabetic patients have shown that Victoza can lower blood glucose and help reduce weight. Further, unlike other oral hypoglycemics, it does not cause a profound drop in blood sugars.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment